↓ Skip to main content

Dove Medical Press

The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review.

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, January 2024
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Readers on

mendeley
4 Mendeley
Title
The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review.
Published in
ClinicoEconomics and Outcomes Research: CEOR, January 2024
DOI 10.2147/ceor.s439725
Pubmed ID
Authors

Santi Aprilianti, Auliasari M Utami, Auliya A Suwantika, Neily Zakiyah, Vanji Ikhsan Azis

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 25%
Student > Postgraduate 1 25%
Unknown 2 50%
Readers by discipline Count As %
Psychology 1 25%
Medicine and Dentistry 1 25%
Unknown 2 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2024.
All research outputs
#17,882,207
of 26,181,776 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#334
of 533 outputs
Outputs of similar age
#201,295
of 373,457 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#2
of 4 outputs
Altmetric has tracked 26,181,776 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 533 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 373,457 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.